Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...

Diabetes is the eighth leading cause of death in the US and can lead to other conditions, including kidney failure, ...

This raises their risk of getting fractures by 6 to 12 times. Also fractures take much longer to heal and if any surgery is ...

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

The type 2 diabetes medication Ozempic has been hugely popular when prescribed off-label for weight loss, thanks to its ...

Dr. Darien Sutton and Dr. Stephanie Widmer discuss new studies, which found GLP-1 weight loss drugs beneficial in fighting ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

AstraZeneca PLC aims for $80 billion revenue by 2030 through strong growth in oncology, biopharmaceuticals, and rare diseases ...

Real-time index price for TSX Comp Carbon Price Risk 2030 Adj Index (XECP), along with buy or sell indicators, analysis, ...

REMAIN-1 weight maintenance pivotal study enrollment progressing rapidly; mid-point data analysis expected in Q2 2025 ...